TherapeuticsMD (TXMD) Misses Q3 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- Oil prices jump 4% as fresh US-Iran fighting stokes supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- Dell again lifts annual forecasts as AI demand powers record results
- Fed’s Barr backs rate hike if inflation fails to cool, September odds hit 66%
TherapeuticsMD (TXMD) Appoints Hugh O’Dowd as CEO
November 11, 2021 6:45 AM ESTTherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative, leading womens healthcare company, today announced key leadership changes, including the appointment of Hugh ODowd, the Companys current President, as the Companys Chief Executive Officer and member of the board of directors. Mr. ODowd will succeed Robert G. Finizio, the Companys Co-founder and current Chief Executive Officer, effective on or before December 31, 2021. Mr. Finizio will continue with the Company and has been appointed Vice Chair of the Board of Directors.
I want to thank Rob for his strong leadership and vision over the past 13... More
